Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558)
HKEX:1558
Holding HK:1558?
Track your performance easily
1558 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$7.91 - HK$13.30
Previous CloseHK$9.34
Volume1.35M
Average Volume (3M)2.39M
Market Cap
HK$8.22B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)4.6
Beta0.53
Next Earnings
Mar 21, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 29, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)2.02
Shares OutstandingN/A
10 Day Avg. Volume2,188,272
30 Day Avg. Volume2,391,845
Standard Deviation0.17
R-Squared0.14
Alpha-0.00087
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)8.30
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$13.80Price Target Upside47.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H News
PremiumCompany Announcements
YiChang HEC Strikes Lucrative Licensing Deal with Apollo
PremiumCompany Announcements
YiChang HEC ChangJiang’s Privatization Progress Update
PremiumCompany Announcements
YiChang HEC ChangJiang’s Resolutions Passed Amidst Strong Shareholder Turnout
PremiumCompany Announcements
YiChang HEC Pharmaceutical’s Key 2024 Meeting
PremiumCompany Announcements
YiChang HEC Pharmaceutical Merger Update
PremiumCompany Announcements
YiChang HEC Delays Key Information Circular
PremiumCompany Announcements
YiChang HEC Boosts Annual Service Caps
PremiumCompany Announcements
YiChang HEC Merger Progress and Investor CautionOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.21% Mutual Funds
― Other Institutional Investors
94.88% Public Companies and
Individual Investors
1558 FAQ
What was YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s price range in the past 12 months?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H lowest stock price was HK$7.91 and its highest was HK$13.30 in the past 12 months.
What is YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s market cap?
Currently, no data Available
When is YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s upcoming earnings report date?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s upcoming earnings report date is Mar 21, 2025 which is in 118 days.
How were YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s earnings last quarter?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H released its earnings results on Aug 30, 2024. The company reported HK$0.838 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.838.
Is YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H overvalued?
According to Wall Street analysts YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s price is currently Undervalued.
Does YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H pay dividends?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H pays a Annually dividend of HK$0.11 which represents an annual dividend yield of N/A. See more information on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H dividends here
What is YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s EPS estimate?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H have?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has 653,767,700 shares outstanding.
What happened to YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H’s price movement after its last earnings report?
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H reported an EPS of HK$0.838 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.17%.
Which hedge fund is a major shareholder of YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1558
---
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.60%
12-Months-Change
Fundamentals
Return on Equity
21.26%
Trailing 12-Months
Asset Growth
-7.44%
Trailing 12-Months
Company Description
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic and cardiovascular diseases. The company's major revenue driver is the anti-viral product division, which manufactures its key product, Kewei. It is one of the leading products in China's anti-influenza market. Its other products include Ertongshu, Oumeining, Xinhaining, and Xining which cure diseases such as hypertension and allergy.
---
1558 Stock 12 Month Forecast
Average Price Target
HK$13.80
▲(47.75% Upside)
Technical Analysis
Viva Biotech Holdings
―
China Boqi Environmental (Holding) Co., Ltd.
―
Hansoh Pharmaceutical Group Company Limited
―
Best Analysts Covering 1558
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+18.90%
reiterated a buy rating 2 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +18.90% per trade.
---